Sensus Healthcare (SRTS) Research & Development (2016 - 2025)

Sensus Healthcare has reported Research & Development for 10 years, with the latest figure at $1.9 million in Q4 2025.

• On a quarterly basis, Research & Development rose 34.14% year-over-year to $1.9 million in Q4 2025; TTM through Dec 2025 was $7.8 million, a 56.25% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, up 56.25% from the prior year.
• Research & Development was $1.9 million for Q4 2025 at Sensus Healthcare, up from $1.8 million in the prior quarter.
• The five-year high for Research & Development was $2.6 million in Q1 2025, with the low at $625000.0 in Q4 2023.
• Average Research & Development over 5 years is $1.5 million, with a median of $1.4 million recorded in 2021.
• The sharpest annual moves came in 2023 and 2024: Research & Development sank 60.34% in 2023, then jumped 124.48% in 2024.
• Over 5 years, Research & Development stood at $1.3 million in 2021, then rose by 17.96% to $1.6 million in 2022, then tumbled by 60.34% to $625000.0 in 2023, then surged by 124.48% to $1.4 million in 2024, then jumped by 34.14% to $1.9 million in 2025.
• The last three Research & Development figures came in at $1.9 million (Q4 2025), $1.8 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.